All Stories

  1. A Summary of Guidance on Addressing Racial and Ethnic Health Equity in Systematic Reviews and Evidence-Based Guidelines
  2. Addressing Racial and Ethnic Health Equity in Systematic Reviews and Evidence-Based Guidelines: Overview and Background for the Series
  3. Balancing Priorities in Guideline Development: Consideration of Health Equity in WHO’s Normative Products on Obesity
  4. Campbell and Cochrane evidence on promoting cognitive capacity across life course: a mapping review
  5. The Importance of Trust Among Older Adults Throughout the Social Prescribing Pathway: A Mixed-Methods Analysis
  6. Terminology and Definitions of Racial Health Equity in Prominent Health Websites: Systematic Review
  7. Seven principles for integrating health equity considerations in the practice guideline enterprise
  8. Inequities in glaucoma research: an analysis of Cochrane systematic reviews and randomized trials
  9. Home-Based Nonimmersive Virtual Reality Training After Discharge From Inpatient or Outpatient Stroke Rehabilitation: Parallel Feasibility Randomized Controlled Trial
  10. A Protocol for AI-Powered Tools to Enhance Mobility and Function in Older Adults: An Evidence and Gap Map
  11. Paper 1: introduction to the series
  12. Paper 5: a methodological overview of methods and interventions
  13. Guidance for engagement in health guideline development: A scoping review
  14. Campbell Standards: Modernizing Campbell's Methodologic Expectations for Campbell Collaboration Intervention Reviews (MECCIR)
  15. Recruitment, retention and reporting of variables related to ethnic diversity in randomised controlled trials: an umbrella review
  16. Home-Based Nonimmersive Virtual Reality Training After Discharge From Inpatient or Outpatient Stroke Rehabilitation: Parallel Feasibility Randomized Controlled Trial (Preprint)
  17. Rapid review method series: interim guidance for the reporting of rapid reviews
  18. “We are not invited”: Australian focus group results on how to improve ethnic diversity in trials
  19. PROTOCOL: Effects of social prescribing for older adults: An evidence and gap map
  20. Operationalizing the GRADE-equity criterion to inform guideline recommendations: application to a medical cannabis guideline
  21. Barriers and enablers to and strategies for promoting domestic plasma donation throughout the world: Overarching protocol for three systematic reviews
  22. Can a replication revolution resolve the duplication crisis in systematic reviews?
  23. Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study
  24. Research—What is it good for? Absolutely nothing… unless it is used to inform policy and practice
  25. Epidemiology and development economics two sides of the same coin in impact evaluation
  26. Scoping review of evidence for managing postnatal hypoglycaemia
  27. Sex and Gender Appraisal Tool-Systematic Reviews-2 and Participation-To-Prevalence Ratio assessed to whom the evidence applies in sepsis reviews
  28. Health and social interventions to restore physical function of older adults post-hip fracture: a scoping review
  29. Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working Group
  30. When to replicate systematic reviews of interventions: consensus checklist
  31. Deworming children for soil-transmitted helminths in low and middle-income countries: systematic review and individual participant data network meta-analysis
  32. Deworming in non-pregnant adolescent girls and adult women: a systematic review and meta-analysis
  33. Open Availability of Patient Medical Photographs in Google Images Search Results: Cross-Sectional Study of Transgender Research
  34. The Future of the Campbell Collaboration
  35. Reporting of sex and gender in randomized controlled trials in Canada: a cross-sectional methods study
  36. Open Availability of Patient Medical Photographs in Google Images Search Results: Cross-Sectional Study of Transgender Research
  37. Methodological Rigor in Preclinical Cardiovascular Studies
  38. Assessing the complexity of interventions within systematic reviews: development, content and use of a new tool (iCAT_SR)
  39. Deprescribing versus continuation of chronic proton pump inhibitor use in adults
  40. Documenting research with transgender and gender diverse people: protocol for an evidence map and thematic analysis
  41. Sex Bias Is Increasingly Prevalent in Preclinical Cardiovascular Research: Implications for Translational Medicine and Health Equity for Women
  42. Equity issues were not fully addressed in Cochrane human immunodeficiency virus systematic reviews
  43. Mass deworming to improve developmental health and wellbeing of children in low-income and middle-income countries: a systematic review and network meta-analysis
  44. Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review
  45. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement
  46. The effectiveness of evidence summaries on health policymakers and health system managers use of evidence from systematic reviews: a systematic review
  47. Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid
  48. Education of health professionals for preventing diabetic foot ulceration
  49. Strategies to improve the implementation of healthy eating, physical activity and obesity prevention policies, practices or programmes within childcare services
  50. Development and Alpha-testing of a Stepped Decision Aid for Patients Considering Nonsurgical Options for Knee and Hip Osteoarthritis Management
  51. Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
  52. Reporting guidelines for realist evaluations seek to improve clarity and transparency
  53. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement
  54. Critical EPICOT items were absent in Cochrane human immunodeficiency virus systematic reviews: a bibliometric analysis
  55. Improving GRADE evidence tables part 1: a randomized trial shows improved understanding of content in summary of findings tables with a new format
  56. A scoping review identifies multiple emerging knowledge synthesis methods, but few studies operationalize the method
  57. Costs, and cost-outcome of school feeding programmes and feeding programmes for young children. Evidence and recommendations
  58. Incorporating equity issues into the development of Colombian clinical practice guidelines: suggestions for the GRADE approach
  59. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration
  60. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration
  61. Patient-centered rapid reviews will drive local decision making: commentary on Hartling et al.
  62. Including migrant populations in health impact assessments
  63. Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials
  64. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration
  65. Do evidence summaries increase policy-makers’ use of evidence from systematic reviews: A systematic review protocol
  66. Can Cochrane Reviews inform decisions to improve indigenous people's health?
  67. Complex interventions and their implications for systematic reviews: A pragmatic approach
  68. Water fluoridation for the prevention of dental caries
  69. Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures
  70. Comparison between the standard and a new alternative format of the Summary-of-Findings tables in Cochrane review users: study protocol for a randomized controlled trial
  71. Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making
  72. Interventions to increase the use of electronic health information by healthcare practitioners to improve clinical practice and patient outcomes
  73. Food supplementation for improving the physical and psychosocial health of socio-economically disadvantaged children aged three months to five years
  74. Effect of rapid HIV testing on HIV incidence and services in populations at high risk for HIV exposure: an equity-focused systematic review
  75. Deep transverse friction massage for treating lateral elbow or lateral knee tendinitis
  76. Development and Evaluation of ‘Briefing Notes’ as a Novel Knowledge Translation Tool to Aid the Implementation of Sex/Gender Analysis in Systematic Reviews: A Pilot Study
  77. Oral or transdermal opioids for osteoarthritis of the knee or hip
  78. Global Burden of Skin Disease as Reflected in Cochrane Database of Systematic Reviews
  79. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health
  80. Update of Strategies to Translate Evidence from Cochrane Musculoskeletal Group Systematic Reviews for Use by Various Audiences
  81. ‘It is surely a great criticism of our profession…’ The next 20 years of equity-focused systematic reviews
  82. A research and development agenda for systematic reviews that ask complex questions about complex interventions
  83. Assessing the applicability of findings in systematic reviews of complex interventions can enhance the utility of reviews for decision making
  84. Complex interventions and their implications for systematic reviews: a pragmatic approach
  85. Introducing a series of methodological articles on considering complexity in systematic reviews of interventions
  86. Including Health Equity Considerations in Development of Instruments for Rheumatology Research: An Introduction to a Novel OMERACT Paradigm
  87. Testing the PRISMA-Equity 2012 Reporting Guideline: the Perspectives of Systematic Review Authors
  88. Realist review to understand the efficacy of culturally appropriate diabetes education programmes
  89. Health equity: evidence synthesis and knowledge translation methods
  90. Prevention and self-management interventions are top priorities for osteoarthritis systematic reviews
  91. An equity lens can ensure an equity-oriented approach to agenda setting and priority setting of Cochrane Reviews
  92. Ensuring relevance for Cochrane reviews: evaluating processes and methods for prioritizing topics for Cochrane reviews
  93. Evidence in agenda setting: new directions for the Cochrane Collaboration
  94. Prioritization of systematic reviews leads prioritization of research gaps and needs
  95. The Uptake of Integrated Perinatal Prevention of Mother-to-Child HIV Transmission Programs in Low- and Middle-Income Countries: A Systematic Review
  96. Clinical practice guidelines for osteoarthritis
  97. Assessing and Comparing Global Health Competencies in Rehabilitation Students
  98. Systematic reviews need to consider applicability to disadvantaged populations: inter-rater agreement for a health equity plausibility algorithm
  99. PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity
  100. What types of interventions generate inequalities? Evidence from systematic reviews: Table 1
  101. What is the most appropriate knowledge synthesis method to conduct a review? Protocol for a scoping review
  102. Integrating Prevention of Mother-to-Child HIV Transmission Programs to Improve Uptake: A Systematic Review
  103. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
  104. Does Consideration and Assessment of Effects on Health Equity Affect the Conclusions of Systematic Reviews? A Methodology Study
  105. Ottawa Panel evidence-based clinical practice guidelines for patient education in the management of Rheumatoid Arthritis (RA)
  106. Influencing Health Equity: Role of the Effective Consumer Scale in Measuring Skills and Abilities in a Middle Income Country
  107. Damned if you do, damned if you don't: subgroup analysis and equity
  108. Ottawa Panel Evidence-Based Clinical Practice Guidelines for the Management of Osteoarthritis in Adults Who Are Obese or Overweight
  109. Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 3 of 3. The GRADE approach to developing recommendations
  110. Reaching those most in need: A scoping review of interventions to improve health care quality for disadvantaged populations with osteoarthritis
  111. Assessing equity in systematic reviews: realising the recommendations of the Commission on Social Determinants of Health
  112. Evaluation of evidence-based literature and formulation of recommendations for the clinical preventive guidelines for immigrants and refugees in Canada
  113. Evidence-based clinical guidelines for immigrants and refugees
  114. Knowledge translation: An opportunity to reduce global health inequalities
  115. Assessing Quality of Sleep in Patients with Rheumatoid Arthritis
  116. Progress on Incorporating the Patient Perspective in Outcome Assessment in Rheumatology and the Emergence of Life Impact Measures at OMERACT 9
  117. Responsiveness of the Effective Consumer Scale (EC-17)
  118. The OMERACT Initiative. Towards a Reference Approach to Derive QALY for Economic Evaluations in Rheumatology
  119. Equity-oriented toolkit for health technology assessment and knowledge translation: application to scaling up of training and education for health workers
  120. Better evidence about wicked issues in tackling health inequities
  121. Electronic retrieval of health information by healthcare providers to improve practice and patient care
  122. How effects on health equity are assessed in systematic reviews of interventions
  123. Is health equity considered in systematic reviews of the cochrane musculoskeletal group?
  124. Oral or transdermal opioids for osteoarthritis of the knee or hip
  125. Funding agencies in low- and middle-income countries: support for knowlege translation
  126. Ottawa Panel Evidence-Based Clinical Practice Guidelines for Aerobic Fitness Exercises in the Management of Fibromyalgia: Part 1
  127. Ottawa Panel Evidence-Based Clinical Practice Guidelines for Strengthening Exercises in the Management of Fibromyalgia: Part 2
  128. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
  129. Direct costs of osteoporosis and hip fracture: an analysis for the Mexican healthcare system
  130. Realist review to understand the efficacy of school feeding programmes
  131. Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse
  132. Assessing equity in clinical practice guidelines
  133. School feeding for improving the physical and psychosocial health of disadvantaged students
  134. Investigating the decision-making needs of HIV-positive women in Africa using the Ottawa Decision-Support Framework: Knowledge gaps and opportunities for intervention
  135. Reduction of inequalities in health: assessing evidence-based tools
  136. Systematic reviews and knowledge translation
  137. International clinical epidemiology network
  138. Health Research Profile to assess the capacity of low and middle income countries for equity-oriented research
  139. Cochrane and Campbell Collaborations, and health equity
  140. Ottawa Panel Evidence-Based Clinical Practice Guidelines for Post-Stroke Rehabilitation
  141. Applying clinical epidemiological methods to health equity: the equity effectiveness loop
  142. Consumer-driven health care: Building partnerships in research
  143. Transcutaneous Electrical Nerve Stimulation for the Treatment of Chronic Low Back Pain: A Systematic Review
  144. The role of clinical epidemiology in health equity: Let's take action!
  145. Glucosamine therapy for treating osteoarthritis
  146. Risedronat zur Prävention und Therapie der postmenopausalen Osteoporose
  147. Number needed to treat (NNT): implication in rheumatology clinical practice
  148. Thermotherapie zur Behandlung der rheumatoiden Arthritis
  149. Transkutane elektrische Nervenstimulation bei Osteoarthritis des Kniegelenks
  150. VII. Meta-Analysis of Calcium Supplementation for the Prevention of Postmenopausal Osteoporosis
  151. VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis
  152. III. Meta-Analysis of Risedronate for the Treatment of Postmenopausal Osteoporosis
  153. V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women
  154. II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women
  155. Meta-Analyses of Therapies for Postmenopausal Osteoporosis
  156. IV. Meta-Analysis of Raloxifene for the Prevention and Treatment of Postmenopausal Osteoporosis
  157. Leflunomide for the treatment of rheumatoid arthritis
  158. Prävention NSAR-induzierter Gastroduodenalulzera
  159. Massage bei Kreuzschmerzen
  160. Transkutane elektrische Nervenstimulation (TENS) bei chronischen Kreuzschmerzen
  161. Efficacy of the Transcutaneous Electrical Nerve Stimulation for the Treatment of Chronic Low Back Pain
  162. A Meta-analysis of Etidronate for the Treatment of Postmenopausal Osteoporosis
  163. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis
  164. Cost Effectiveness of Nasal Calcitonin in Postmenopausal Women
  165. Do silicone breast implants cause rheumatologic disorders?: A systematic review for a Court-Appointed National Science Panel
  166. Fluoride for the Treatment of Postmenopausal Osteoporotic Fractures: A Meta-Analysis